Patents by Inventor ZEALAND PHARMA A/S

ZEALAND PHARMA A/S has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED LYSINE-MIMETIC COMPOUNDS
    Publication number: 20130225644
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: April 1, 2013
    Publication date: August 29, 2013
    Applicant: Zealand Pharma A/S
    Inventor: Zealand Pharma A/S
  • METHODS FOR USING PEPTIDE AGONISTS HAVING GLP-1 ACTIVITY
    Publication number: 20130210722
    Abstract: Novel peptide agonists of GLP-1 activity useful for lowering blood glucose levels. The novel peptides comprise variants of the GLP-1 or the exendin-4 polypeptide sequence and are pharmacologically active and stable. These peptides are useful in the treatment of diseases that benefit from regulation of excess levels of blood glucose and/or regulation of gastric emptying, such as diabetes and eating disorders.
    Type: Application
    Filed: March 26, 2013
    Publication date: August 15, 2013
    Applicant: ZEALAND PHARMA A/S
    Inventor: ZEALAND PHARMA A/S